DAM
JBIO

Deltec Asset Management’s Jade Biosciences JBIO Stock Holding History

Deltec Asset Management’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$210K Sell
9,436
-6,320
-40% -$132K 0.03% 239
2026
Q1 		$221K Hold
15,756
– – 0.04% 210
2025
Q4 		$243K Hold
15,756
– – 0.04% 193
2025
Q3 		$136K Hold
15,756
– – 0.02% 195
2025
Q2 		$157K Buy
15,756
+5,419
+52% +$184K 0.03% 180
2025
Q1 		$908K Buy
10,337
+4,791
+86% +$421K 0.2% 86
2024
Q4 		$514K Buy
+5,546
New +$478K 0.1% 114

Other funds holding JBIO

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

Deltec Asset Management's JBIO Position: Q2 2026 in Review

Deltec Asset Management reduced its Jade Biosciences (JBIO) stake by 40% in Q2 2026, selling an estimated $132K and leaving 9,436 shares worth $210K. The position accounts for 0.03% of the portfolio, ranked #239.

Deltec Asset Management first reported a position in JBIO in Q4 2024 and has held it in 7 quarters since. The position peaked at $908K in Q1 2025. 25 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Deltec Asset Management held 9,436 shares of Jade Biosciences worth $210K as of Q2 2026.
  • Deltec Asset Management sold 6,320 Jade Biosciences shares in Q2 2026, an estimated $132K.
  • Jade Biosciences made up 0.03% of Deltec Asset Management's portfolio in Q2 2026, its #239 holding.
  • Deltec Asset Management first reported a position in Jade Biosciences in Q4 2024 and has held it in 7 quarters since.
  • Deltec Asset Management's Jade Biosciences position peaked at $908K in Q1 2025.
  • 25 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Deltec Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.